Kevin K., Qing M., Laura W., Frederic S., Jérôme D., Peter K., David H., Pouya F., Chen L., Anthony P., Anne J., Eustache P., Marco T., Lukas R., Roland B., Joël L., Éric B., Mathieu C., Pierre T., Etienne C., Isabelle S. MCP
Mass spectrometry (MS)-based immunopeptidomics is a rapidly evolving, automated, and high-throughput technology that produces small- to large-scale datasets of clinically relevant MHC class I- and II-associated peptides. This technology requires the development of software tools for the rapid and simultaneous quality control of large clinical immunopeptidomic studies. Biognosys’ researchers joined an international collaborative effort to develop MhcVizPipe, a semi-automated, fast post-acquisition tool for the assessment of sample quality and MHC-specificity through powerful data visualization and reporting.
Access our knowledge base with relevant resources and guiding information.